2BB score and signals
Dermata Therapeutics, Inc.’s current 2BB score is 24 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 12 | Very Low |
| Momentum | 50 | Stable |
| Quality | 20 | Weak |
Dermata Therapeutics, Inc. (DRMA) Stock Score & Signals
Dermata Therapeutics, Inc. (DRMA) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 24 out of 100.
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-03-24 | — | -0.4692 | — | $76,500.00 |
| 2026-11-12 | — | -0.561 | — | $25,500.00 |
| 2026-08-11 | — | -0.561 | — | $0.00 |
| 2026-05-12 | — | -0.7344 | — | — |